Search

To compare the increase in platelet count after the transfusion of apheresis and pooled platelet suspensions among patients in the internal medicine intensive care unit. Methods Patients who received platelet suspension transfusions and were followed up at the internal medicine intensive care unit at Mehmet Akif Inan Training and Research Hospital were evaluated. The patient’s platelet counts were administered apheresis, and pooled platelet suspensions were recorded before and after transfusion. The increase in platelet count was calculated. The two groups were statistically compared. Results: A total of 4,701 platelet suspension transfusions were performed at our hospital between January 1, 2020, and December 31, 2023. Of these transfusions, 2,990 belonged to pooled platelet suspensions and 1,711 to apheresis platelet suspensions. Conclusion: Platelet suspension transfusion is frequently used in patients receiving internal medicine intensive care. However, there is an ongoing debate concerning whether apheresis or pooled platelet transfusion is more effective in increasing platelet count. In this study, we found a significantly higher increase in platelet count among patients in the internal medicine intensive care unit after apheresis platelet suspension transfusion than pooled platelet suspension transfusion. [ABSTRACT FROM AUTHOR]

Purpose: Blood banking is critical for patients who require transfusions. Blood banks must stock blood products and update their inventory depending on the transfusion demands of hospitals. This demand subject to fluctuations caused by factors such as seasonal variations, emergent medical situations, and disasters. Unexpected changes in transfusion demand also have the potential to affect the number of waste blood products, thereby exacerbating the economic burden borne by blood centers. Our aim in this study is to reduce the destruction rates of blood products. Materials and Methods: In this study, we evaluated the number and cause of discarded blood products in a tertiary hospital in the southeast of Turkey between 2019 and 2022. We also analyzed the effect of the COVID-19 pandemic on blood product waste. In addition, we developed a four-step protocol to reduce wasted blood products in our center. Results: In the first year of the study, the waste/stock (W/S) ratio was 3.0% for packed red blood cells (pRBCs) and 9.2% for platelets (PLTs). However, this ratio increased to 3.2% for pRBCs and 10.1% for PLTs during the COVID-19 restrictions in 2020. Upon the implementation of the four-step protocol, the W/S ratio decreased for both pRBCs (2.3%) and PLTs (6.9%) in 2021, but this trend continued for only pRBCs (1.8%) in 2022. Conclusion: The number of waste products increased during the COVID-19 restrictions in our center. After we developed the four-step protocol, the waste of pRBCs decreased for two consecutive years, but this was not observed for other blood products. To verify our results, the presented 4-step protocol should be tested in a larger center over a longer period. [ABSTRACT FROM AUTHOR]

Copyright of Van Tip Dergisi is the property of Yuzuncu Yil University, Faculty of Medicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)